What Is the Impact of the 2017 Cochrane Systematic Review and Meta-Analysis That Evaluated the Use of PCSK9 Inhibitors for Lowering Cardiovascular Disease and Mortality?
Document Type
Article
Publication Date
2018
Publication Title
Expert Opinion on Pharmacotherapy
DOI
10.1080/14656566.2018.1464558
Recommended Citation
Jalloh, M. A., Doroudgar, S., & Ip, E. J. (2018). What Is the Impact of the 2017 Cochrane Systematic Review and Meta-Analysis That Evaluated the Use of PCSK9 Inhibitors for Lowering Cardiovascular Disease and Mortality?. Expert Opinion on Pharmacotherapy, 19 (7), 739-741. https://doi.org/10.1080/14656566.2018.1464558
Publisher's Statement
The original material can be found here: https://doi.org/10.1080/14656566.2018.1464558
